Macrophages, Granulomas, and Bacterial Persistence

巨噬细胞、肉芽肿和细菌持久性

基本信息

  • 批准号:
    9277403
  • 负责人:
  • 金额:
    $ 23.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-06-01 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

Summary Salmonella enterica subspecies Typhimurium is a natural pathogen of mice that establishes persistent, systemic infection. Salmonella generally reside within professional phagocytes, typically macrophages, which is critical for the development of chronic infection. However, it is unclear how Salmonella can survive within a cell-type that evolved to destroy pathogens. Our lab has demonstrated that during persistent murine infections, S. Typhimurium can reside within macrophages that are hemophagocytic. Hemophagocytic macrophages (HMФs) are characterized by the ingestion of viable cells of the hematopoietic lineages, and are clinically associated with human Typhoid fever. We have also observed that by three weeks post-infection, activated macrophages, and possibly HMФs, coalesce into granulomas that harbor and appear to protect bacteria from the host immune system, potentially establishing a site at which the bacteria can survive long-term. The goal of this proposal is to determine how S. Typhimurium exploits macrophages, including HMФs and macrophages within granulomas, to withstand host defenses during acute and chronic infection. We are modeling HMФs and granulomas and the following two aims will address key questions regarding how bacteria establish and maintain colonization of tissues within HMФs and granulomas: 1) How does S. Typhimurium acquire iron from macrophages? and 2) How does S. Typhimurium survive in granulomas? How granulomas form and acquire and maintain bacteria such as Salmonella remains a poorly understood area that may be able to be targeted with therapeutics.
概括 肠沙门氏菌亚种鼠伤寒是小鼠的天然病原体,可建立持久的、系统性的 感染。沙门氏菌通常驻留在专业吞噬细胞(通常是巨噬细胞)内,这一点至关重要 发展为慢性感染。然而,尚不清楚沙门氏菌如何在细胞类型中生存 进化来消灭病原体。我们的实验室已经证明,在小鼠持续感染期间,S. 鼠伤寒杆菌可驻留在噬血细胞的巨噬细胞内。噬血细胞巨噬细胞 (HMФs) 其特征是摄入造血谱系的活细胞,并且在临床上与 人类伤寒。我们还观察到,感染后三周,巨噬细胞和 可能是 HMФ,合并成肉芽肿,并似乎可以保护细菌免受宿主免疫的影响 系统,有可能建立一个细菌可以长期生存的场所。该提案的目标是 确定鼠伤寒沙门氏菌如何利用巨噬细胞,包括肉芽肿内的 HMФ 和巨噬细胞, 在急性和慢性感染期间抵抗宿主的防御。我们正在对 HMФ 和肉芽肿进行建模 以下两个目标将解决有关细菌如何建立和维持定植的关键问题 HMФ 和肉芽肿内的组织: 1) 鼠伤寒沙门氏菌如何从巨噬细胞获取铁?和 2) 鼠伤寒沙门氏菌如何在肉芽肿中存活?肉芽肿如何形成、获得和维持 沙门氏菌等细菌仍然是一个人们知之甚少的领域,但这些领域可能能够成为治疗的目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Corrella S Detweiler其他文献

Corrella S Detweiler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Corrella S Detweiler', 18)}}的其他基金

Using Salmonella Pathogenesis and Cell Biology as a Discovery Tool
使用沙门氏菌发病机制和细胞生物学作为发现工具
  • 批准号:
    10665946
  • 财政年份:
    2023
  • 资助金额:
    $ 23.1万
  • 项目类别:
Infection-Dependent Vulnerabilities of Gram-negative Bacterial Pathogens
革兰氏阴性细菌病原体的感染依赖性脆弱性
  • 批准号:
    10592676
  • 财政年份:
    2023
  • 资助金额:
    $ 23.1万
  • 项目类别:
A Small Molecule That Blocks Salmonella Replication in Macrophages
阻止沙门氏菌在巨噬细胞中复制的小分子
  • 批准号:
    10312125
  • 财政年份:
    2020
  • 资助金额:
    $ 23.1万
  • 项目类别:
Chemical Probes for Bacteria-Macrophage Interactions
用于细菌-巨噬细胞相互作用的化学探针
  • 批准号:
    9171993
  • 财政年份:
    2016
  • 资助金额:
    $ 23.1万
  • 项目类别:
A Novel Screen for Antibacterials that Are Non-Toxic to Mammals
一种对哺乳动物无毒的抗菌药物的新型筛选
  • 批准号:
    9186486
  • 财政年份:
    2015
  • 资助金额:
    $ 23.1万
  • 项目类别:
A Novel Screen for Antibacterials that Are Non-Toxic to Mammals
一种对哺乳动物无毒的抗菌药物的新型筛选
  • 批准号:
    9015218
  • 财政年份:
    2015
  • 资助金额:
    $ 23.1万
  • 项目类别:
Host Pathways that Enable /Salmonella/ Replication Within Hemophagocytic Macropha
使/沙门氏菌/在噬血细胞巨噬细胞内复制的宿主途径
  • 批准号:
    8281809
  • 财政年份:
    2012
  • 资助金额:
    $ 23.1万
  • 项目类别:
Host Pathways that Enable /Salmonella/ Replication Within Hemophagocytic Macropha
使/沙门氏菌/在噬血细胞巨噬细胞内复制的宿主途径
  • 批准号:
    8418684
  • 财政年份:
    2012
  • 资助金额:
    $ 23.1万
  • 项目类别:
Hemophagocytic Macrophages and Systemic Salmonella Infection
噬血细胞巨噬细胞和全身性沙门氏菌感染
  • 批准号:
    8805824
  • 财政年份:
    2012
  • 资助金额:
    $ 23.1万
  • 项目类别:
Hemophagocytic Macrophages and Systemic Salmonella Infection
噬血细胞巨噬细胞和全身性沙门氏菌感染
  • 批准号:
    8292621
  • 财政年份:
    2012
  • 资助金额:
    $ 23.1万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了